Involved in the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of different diseases.
enVVeno Medical Corporation is a pioneering medical device company specializing in the advancement of bioprosthetic tissue-based solutions aimed at revolutionizing the treatment of venous diseases. Central to its innovation is the development of the VenoValve, a cutting-edge surgical implant designed specifically to address severe deep venous chronic venous insufficiency. Implanted within the femoral vein, the VenoValve functions as a crucial one-way valve, facilitating improved blood flow and restoring proper circulation in the leg.
Headquartered in Irvine, California, enVVeno Medical Corporation was originally founded in 1999 under the name Hancock Jaffe Laboratories, Inc., before rebranding to emphasize its dedication to advancing venous health solutions. Beyond its flagship VenoValve product, the company continues to expand its portfolio of bioprosthetic tissue technologies, driving innovation in the field of vascular surgery. By leveraging extensive research and development efforts, enVVeno Medical Corporation strives to set new standards of care in venous disease treatment, offering hope and improved quality of life for patients worldwide.
The company's commitment to innovation is underscored by its ongoing efforts to enhance patient outcomes through transformative medical solutions. With a strong foundation in biotechnology and a focus on advancing surgical implant technology, enVVeno Medical Corporation stands at the forefront of medical innovation, dedicated to addressing unmet medical needs and improving the lives of individuals suffering from venous disorders.